"Pimafucin" for the treatment of moniliasis: a clinical trial.
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D010866:Natamycin / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*
D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D001548:Benzalkonium Compounds; D010866:Natamycin